AV
ARCH Venture Fund XIII, L.P.
DELAYED 1 MONTH
10% Owner
Lyell Immunopharma, Inc.
Filings
1
Companies
1
Latest
Mar 6, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
—
Lyell Immunopharma, Inc.
ARCH Venture Fund XIII, L.P.
10% Owner
Purchase
$12.5M
488,090 sh
Mar 9 8:34 PM
Mar 6, 2026